Tower Research Capital (TRC)’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,135
| Closed | -$2.84K | – | 6414 |
|
|
2023
Q3 | $2.84K | Sell |
7,135
-15
| -0.2% | -$6 | ﹤0.01% | 5095 |
|
|
2023
Q2 | $4.93K | Buy |
7,150
+6,664
| +1,371% | +$4.6K | ﹤0.01% | 4861 |
|
|
2023
Q1 | $4K | Sell |
486
-5,386
| -92% | -$44.3K | ﹤0.01% | 5159 |
|
|
2022
Q4 | $5K | Sell |
5,872
-1,689
| -22% | -$1.44K | ﹤0.01% | 4961 |
|
|
2022
Q3 | $8K | Sell |
7,561
-3,064
| -29% | -$3.24K | ﹤0.01% | 4854 |
|
|
2022
Q2 | $13K | Buy |
10,625
+9,049
| +574% | +$11.1K | ﹤0.01% | 4263 |
|
|
2022
Q1 | $4K | Buy |
1,576
+878
| +126% | +$2.23K | ﹤0.01% | 5335 |
|
|
2021
Q4 | $2K | Buy |
+698
| New | +$2K | ﹤0.01% | 5765 |
|
|
2021
Q2 | – | Sell |
-2,131
| Closed | -$11K | – | 6339 |
|
|
2021
Q1 | $11K | Buy |
2,131
+689
| +48% | +$3.56K | ﹤0.01% | 4353 |
|
|
2020
Q4 | $10K | Sell |
1,442
-2,110
| -59% | -$14.6K | ﹤0.01% | 4360 |
|
|
2020
Q3 | $36K | Buy |
3,552
+3,381
| +1,977% | +$34.3K | ﹤0.01% | 3671 |
|
|
2020
Q2 | $2K | Buy |
+171
| New | +$2K | ﹤0.01% | 4574 |
|
|
2017
Q4 | – | Sell |
-7
| Closed | – | – | 4419 |
|
|
2017
Q3 | $0 | Buy |
+7
| New | – | ﹤0.01% | 4446 |
|
|
2016
Q4 | – | Sell |
-47
| Closed | -$1K | – | 4710 |
|
|
2016
Q3 | $1K | Sell |
47
-2
| -4% | -$43 | ﹤0.01% | 3445 |
|
|
2016
Q2 | $1K | Hold |
49
| – | – | ﹤0.01% | 4282 |
|
|
2016
Q1 | $2K | Buy |
+49
| New | +$2K | ﹤0.01% | 3519 |
|
|
2015
Q4 | – | Sell |
-13
| Closed | -$1K | – | 5371 |
|
|
2015
Q3 | $1K | Sell |
13
-10
| -43% | -$769 | ﹤0.01% | 3756 |
|
|
2015
Q2 | $3K | Buy |
23
+1
| +5% | +$130 | ﹤0.01% | 3617 |
|
|
2015
Q1 | $3K | Buy |
+22
| New | +$3K | ﹤0.01% | 3643 |
|